Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-04 10:55 am Purchase |
2025-04-02 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 20,432,634 32.800% |
3,790,451 (+22.78%) |
Filing History |
| 2025-03-05 5:55 pm Purchase |
2024-10-29 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 16,642,183 32.380% |
15,429,657 (+1272.52%) |
Filing History |
| 2024-01-05 7:16 pm Purchase |
2023-12-27 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 45,989,871 66.310% |
32,000,317 (+228.74%) |
Filing History |
| 2023-12-22 12:05 pm Unchanged |
2023-12-14 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 1,212,526 19.990% |
0 (Unchanged) |
Filing History |
| 2023-09-07 8:05 pm Purchase |
2023-08-31 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 13,989,554 37.450% |
8,568,949 (+158.08%) |
Filing History |
| 2023-09-07 5:26 pm Purchase |
2023-07-13 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 1,212,526 19.990% |
645,000 (+113.65%) |
Filing History |
| 2023-08-25 8:40 pm Purchase |
2023-07-31 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 5,420,605 19.990% |
986,195 (+22.24%) |
Filing History |
| 2023-01-06 4:36 pm Purchase |
2023-01-02 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 4,434,410 18.700% |
2,304,636 (+108.21%) |
Filing History |
| 2022-12-14 4:30 pm Purchase |
2022-12-02 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 567,526 11.050% |
567,526 (New Position) |
Filing History |
| 2022-09-13 09:42 am Purchase |
2022-05-19 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 2,129,774 11.200% |
2,129,774 (New Position) |
Filing History |
| 2022-03-16 4:30 pm Sale |
2022-03-09 | 13D | BlackRock Technology and Private Equity Term Trust BTX |
Charles Cherington | 295,668 11.400% |
-19,997 (-6.33%) |
Filing History |
| 2021-05-13 5:00 pm Purchase |
2021-03-25 | 13D | BlackRock Technology and Private Equity Term Trust BTX |
Charles Cherington | 315,665 15.200% |
315,665 (New Position) |
Filing History |